Search

Magdalene K. Sgagias

Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
637
Issued Applications
229
Pending Applications
42
Abandoned Applications
366

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9134342 [patent_doc_number] => 20130295056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Generation of Histocompatible Tissues Using Nuclear Transplantation' [patent_app_type] => utility [patent_app_number] => 13/691568 [patent_app_country] => US [patent_app_date] => 2012-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10767 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13691568 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/691568
Generation of Histocompatible Tissues Using Nuclear Transplantation Nov 29, 2012 Abandoned
Array ( [id] => 10051040 [patent_doc_number] => 09090908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Chimeric glycoproteins and pseudotyped lentiviral vectors' [patent_app_type] => utility [patent_app_number] => 13/676852 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 35015 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676852 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/676852
Chimeric glycoproteins and pseudotyped lentiviral vectors Nov 13, 2012 Issued
Array ( [id] => 8842126 [patent_doc_number] => 20130137754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 13/644229 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11981 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644229 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/644229
TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS Oct 2, 2012 Abandoned
Array ( [id] => 9841289 [patent_doc_number] => 20150033371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'HAIR FOLLICLE STEM CELLS AND METHODS OF USE SAME' [patent_app_type] => utility [patent_app_number] => 14/344898 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23273 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344898 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344898
HAIR FOLLICLE STEM CELLS AND METHODS OF USE SAME Sep 12, 2012 Abandoned
Array ( [id] => 9053956 [patent_doc_number] => 20130251670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof' [patent_app_type] => utility [patent_app_number] => 13/615043 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9213 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615043 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/615043
Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof Sep 12, 2012 Abandoned
Array ( [id] => 10946376 [patent_doc_number] => 20140349396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Compositions and Methods Relating to Clonal Progenitor Cells' [patent_app_type] => utility [patent_app_number] => 14/238160 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 32042 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238160 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238160
Compositions and Methods Relating to Clonal Progenitor Cells Sep 9, 2012 Abandoned
Array ( [id] => 8684443 [patent_doc_number] => 20130052727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR AUTOLOGOUS GERMLINE MITOCHONDRIAL ENERGY TRANSFER' [patent_app_type] => utility [patent_app_number] => 13/606914 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 22335 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13606914 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/606914
Compositions for autologous ovarian oogonial stem cell mitochondrial energy transfer Sep 6, 2012 Issued
Array ( [id] => 8698070 [patent_doc_number] => 20130060079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR AUTOLOGOUS GERMLINE MITOCHONDRIAL ENERGY TRANSFER' [patent_app_type] => utility [patent_app_number] => 13/590812 [patent_app_country] => US [patent_app_date] => 2012-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 22081 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590812 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/590812
Compositions and methods for autologous germline mitochondrial energy transfer Aug 20, 2012 Issued
Array ( [id] => 8483285 [patent_doc_number] => 20120282692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Oocytes Derived from Ovarian Culture Initially Containing No Oocytes' [patent_app_type] => utility [patent_app_number] => 13/551685 [patent_app_country] => US [patent_app_date] => 2012-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5415 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13551685 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/551685
Oocytes Derived from Ovarian Culture Initially Containing No Oocytes Jul 17, 2012 Abandoned
Array ( [id] => 8482937 [patent_doc_number] => 20120282344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'FORMULATION FOR THE BIOLOGICAL CONTROL OF INSECT-PESTS' [patent_app_type] => utility [patent_app_number] => 13/548563 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7805 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548563 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/548563
FORMULATION FOR THE BIOLOGICAL CONTROL OF INSECT-PESTS Jul 12, 2012 Abandoned
Array ( [id] => 8464616 [patent_doc_number] => 20120269784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'CARDIAC MUSCLE REPAIR OR REGENERATION USING BONE MARROW-DERIVED STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/540021 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7942 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540021 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/540021
Cardiac muscle repair or regeneration using bone marrow-derived stem cells Jul 1, 2012 Issued
Array ( [id] => 9204895 [patent_doc_number] => 20140004072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Polyethyleneimine And Beta2-Adrenergic Receptor Based Gene Therapy For Acute Lung Injury' [patent_app_type] => utility [patent_app_number] => 13/539300 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6247 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539300 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/539300
Polyethyleneimine And Beta2-Adrenergic Receptor Based Gene Therapy For Acute Lung Injury Jun 28, 2012 Abandoned
Array ( [id] => 8441467 [patent_doc_number] => 20120258083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'PLACENTAL VASCULAR LOBULE STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/527579 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3120 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13527579 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/527579
PLACENTAL VASCULAR LOBULE STEM CELLS Jun 18, 2012 Abandoned
Array ( [id] => 8670987 [patent_doc_number] => 20130045525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'METHOD OF CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/524503 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14834 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524503 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/524503
Method of cancer treatment Jun 14, 2012 Issued
Array ( [id] => 8585641 [patent_doc_number] => 20130004462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'MODIFIED FACTOR VIII AND FACTOR IX GENES AND VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 13/494068 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 10498 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494068 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/494068
Modified factor VIII and factor IX genes and vectors for gene therapy Jun 11, 2012 Issued
Array ( [id] => 9449401 [patent_doc_number] => 20140120571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'PRODUCTION METHOD FOR ARTIFICIAL CANCER STEM CELL AND INDUCED DIFFERENTIATION METHOD THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/122634 [patent_app_country] => US [patent_app_date] => 2012-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8247 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122634 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/122634
Production method for artificial cancer stem cell and induced differentiation method therefor May 23, 2012 Issued
Array ( [id] => 17968467 [patent_doc_number] => 11485984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Method for introducing hepatocyte growth factor and neurogenin 1 into mesenchymal stem cells [patent_app_type] => utility [patent_app_number] => 14/119788 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7784 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119788 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/119788
Method for introducing hepatocyte growth factor and neurogenin 1 into mesenchymal stem cells May 22, 2012 Issued
Array ( [id] => 8683882 [patent_doc_number] => 20130052166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'MATERIALS AND METHODS FOR MINIMALLY-INVASIVE ADMINISTRATION OF A CELL-CONTAINING FLOWABLE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/467180 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18609 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467180 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/467180
MATERIALS AND METHODS FOR MINIMALLY-INVASIVE ADMINISTRATION OF A CELL-CONTAINING FLOWABLE COMPOSITION May 8, 2012 Abandoned
Array ( [id] => 8358595 [patent_doc_number] => 20120213749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/454315 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6712 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454315 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/454315
CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS Apr 23, 2012 Abandoned
Array ( [id] => 9510927 [patent_doc_number] => 20140147418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'AAV MEDIATED CTLA-4 GENE TRANSFER TO TREAT SJOGREN\'S SYNDROME' [patent_app_type] => utility [patent_app_number] => 14/111604 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17580 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111604 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/111604
AAV MEDIATED CTLA-4 GENE TRANSFER TO TREAT SJOGREN'S SYNDROME Apr 12, 2012 Abandoned
Menu